Related Experiment Video
Updated: May 13, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine
Valerie Edmond1, Galina Merdzhanova, Stephanie Gout
1INSERM, U823, Equipe 2 Bases Moléculaires de la Progression des Cancers du Poumon, Grenoble, France.
Abstract:
The transcription factor E2F1 belongs to the E2F family and plays a crucial role during cell cycle progression and apoptosis. Ser/Arg-Rich (SR) proteins are a family of RNA-binding phosphoproteins that control both constitutive and alternative pre-mRNA splicing events. We previously identified the SR protein SRSF2 as a new transcriptional target of E2F1 and demonstrated that both proteins cooperate to induce apoptosis in non-small cell lung carcinoma. In this study, we postulated that SRSF2 is also involved in the proliferative functions of E2F1. Using IHC, we first demonstrate that SRSF2 and its phosphorylated form (P-SRSF2) are overexpressed in neuroendocrine lung tumors that are highly proliferative tumors expressing high levels of E2F1. Importantly, we show a direct correlation between cyclin E, an E2F1-target gene controlling S phase, and P-SRSF2 proteins levels (p = 0.0083), suggesting a role of SRSF2 in E2F1-mediated cellular proliferation. Accordingly, using neuroendocrine lung carcinoma cell lines, we demonstrate that SRSF2 is a cell cycle-regulated protein involved in entry and progression into S phase. We also provide evidence that SRSF2 interacts with E2F1 and stimulates its transcriptional control of cell cycle target genes such as cyclin E. Finally, we show that inhibition of AKT signaling pathway prevents SRSF2 phosphorylation and activity toward E2F1 transcriptional function. Taken together, these results identify a new role of SRSF2 in the control of cell cycle progression and reinforce the functional link between SRSF2 and E2F1 proteins.
Insights
The SR protein SRSF2 promotes cell cycle progression by interacting with E2F1 in lung cancer. Inhibition of AKT signaling blocks SRSF2 phosphorylation and its function in E2F1 transcriptional activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- E2F1 is a transcription factor vital for cell cycle and apoptosis.
- SRSF2 is an RNA-binding protein regulating pre-mRNA splicing.
- E2F1 and SRSF2 cooperate in apoptosis induction in lung cancer.
Purpose of the Study:
- To investigate the role of SRSF2 in the proliferative functions of E2F1.
- To explore the link between SRSF2, E2F1, and cell cycle progression in lung tumors.
Main Methods:
- Immunohistochemistry (IHC) to detect SRSF2 and P-SRSF2 expression.
- Correlation analysis between cyclin E and P-SRSF2 levels.
- Cell cycle analysis in neuroendocrine lung carcinoma cell lines.
- Investigation of SRSF2-E2F1 interaction and AKT signaling inhibition.
Main Results:
- SRSF2 and P-SRSF2 are overexpressed in proliferative neuroendocrine lung tumors with high E2F1.
- A significant correlation exists between cyclin E and P-SRSF2 levels, indicating a role in proliferation.
- SRSF2 is cell cycle-regulated, essential for S phase entry and progression.
- SRSF2 interacts with E2F1, enhancing its transcriptional control of cell cycle genes.
- AKT inhibition reduces SRSF2 phosphorylation and its activity on E2F1.
Conclusions:
- SRSF2 plays a novel role in controlling cell cycle progression.
- A functional link between SRSF2 and E2F1 in cell proliferation is reinforced.
- SRSF2's activity is regulated by AKT signaling in the context of E2F1 function.
Related Concept Videos
RNA Splicing
Negative Regulator Molecules
Mitogens and the Cell Cycle
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of Nuclear Protein Sorting
Abnormal Proliferation

